These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 22078793)

  • 1. Simulation of a MR-PET protocol for staging of head-and-neck cancer including Dixon MR for attenuation correction.
    Eiber M; Souvatzoglou M; Pickhard A; Loeffelbein DJ; Knopf A; Holzapfel K; Martinez-Möller A; Nekolla SG; Scherer EQ; Schwaiger M; Rummeny EJ; Beer AJ
    Eur J Radiol; 2012 Oct; 81(10):2658-65. PubMed ID: 22078793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated whole-body PET/MR hybrid imaging: clinical experience.
    Quick HH; von Gall C; Zeilinger M; Wiesmüller M; Braun H; Ziegler S; Kuwert T; Uder M; Dörfler A; Kalender WA; Lell M
    Invest Radiol; 2013 May; 48(5):280-9. PubMed ID: 23442775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck.
    Rodrigues RS; Bozza FA; Christian PE; Hoffman JM; Butterfield RI; Christensen CR; Heilbrun M; Wiggins RH; Hunt JP; Bentz BG; Hitchcock YJ; Morton KA
    J Nucl Med; 2009 Aug; 50(8):1205-13. PubMed ID: 19617339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First clinical experience with integrated whole-body PET/MR: comparison to PET/CT in patients with oncologic diagnoses.
    Drzezga A; Souvatzoglou M; Eiber M; Beer AJ; Fürst S; Martinez-Möller A; Nekolla SG; Ziegler S; Ganter C; Rummeny EJ; Schwaiger M
    J Nucl Med; 2012 Jun; 53(6):845-55. PubMed ID: 22534830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous reconstruction of activity and attenuation for PET/MR.
    Salomon A; Goedicke A; Schweizer B; Aach T; Schulz V
    IEEE Trans Med Imaging; 2011 Mar; 30(3):804-13. PubMed ID: 21118768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous PET/MR imaging in a human brain PET/MR system in 50 patients--current state of image quality.
    Schwenzer NF; Stegger L; Bisdas S; Schraml C; Kolb A; Boss A; Müller M; Reimold M; Ernemann U; Claussen CD; Pfannenberg C; Schmidt H
    Eur J Radiol; 2012 Nov; 81(11):3472-8. PubMed ID: 22260898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
    Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue classification as a potential approach for attenuation correction in whole-body PET/MRI: evaluation with PET/CT data.
    Martinez-Möller A; Souvatzoglou M; Delso G; Bundschuh RA; Chefd'hotel C; Ziegler SI; Navab N; Schwaiger M; Nekolla SG
    J Nucl Med; 2009 Apr; 50(4):520-6. PubMed ID: 19289430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.
    Ng SH; Yen TC; Liao CT; Chang JT; Chan SC; Ko SF; Wang HM; Wong HF
    J Nucl Med; 2005 Jul; 46(7):1136-43. PubMed ID: 16000282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-enhanced PET/MR imaging versus contrast-enhanced PET/CT in head and neck cancer: how much MR information is needed?
    Kuhn FP; Hüllner M; Mader CE; Kastrinidis N; Huber GF; von Schulthess GK; Kollias S; Veit-Haibach P
    J Nucl Med; 2014 Apr; 55(4):551-8. PubMed ID: 24491410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffusion-weighted imaging as part of hybrid PET/MRI protocols for whole-body cancer staging: does it benefit lesion detection?
    Buchbender C; Hartung-Knemeyer V; Beiderwellen K; Heusch P; Kühl H; Lauenstein TC; Forsting M; Antoch G; Heusner TA
    Eur J Radiol; 2013 May; 82(5):877-82. PubMed ID: 23428414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
    Eiber M; Takei T; Souvatzoglou M; Mayerhoefer ME; Fürst S; Gaertner FC; Loeffelbein DJ; Rummeny EJ; Ziegler SI; Schwaiger M; Beer AJ
    J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of feasibility and image quality of 68Ga-DOTATOC positron emission tomography/magnetic resonance in comparison with positron emission tomography/computed tomography in patients with neuroendocrine tumors.
    Gaertner FC; Beer AJ; Souvatzoglou M; Eiber M; Fürst S; Ziegler SI; Brohl F; Schwaiger M; Scheidhauer K
    Invest Radiol; 2013 May; 48(5):263-72. PubMed ID: 23385399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance-based attenuation correction for PET/MR hybrid imaging using continuous valued attenuation maps.
    Navalpakkam BK; Braun H; Kuwert T; Quick HH
    Invest Radiol; 2013 May; 48(5):323-32. PubMed ID: 23442772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Segmentation-based attenuation correction in positron emission tomography/magnetic resonance: erroneous tissue identification and its impact on positron emission tomography interpretation.
    Brendle C; Schmidt H; Oergel A; Bezrukov I; Mueller M; Schraml C; Pfannenberg C; la Fougère C; Nikolaou K; Schwenzer N
    Invest Radiol; 2015 May; 50(5):339-46. PubMed ID: 25585210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Objective and subjective comparison of standard 2-D and fully 3-D reconstructed data on a PET/CT system.
    Strobel K; Rüdy M; Treyer V; Veit-Haibach P; Burger C; Hany TF
    Nucl Med Commun; 2007 Jul; 28(7):555-9. PubMed ID: 17538397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the attenuation properties of MR equipment for its use in a whole-body PET/MR scanner.
    Delso G; Martinez-Möller A; Bundschuh RA; Ladebeck R; Candidus Y; Faul D; Ziegler SI
    Phys Med Biol; 2010 Aug; 55(15):4361-74. PubMed ID: 20647598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor volume assessment by 18F-FDG PET/CT in patients with oral cavity cancer with dental artifacts on CT or MR images.
    Baek CH; Chung MK; Son YI; Choi JY; Kim HJ; Yim YJ; Ko YH; Choi J; Cho JK; Jeong HS
    J Nucl Med; 2008 Sep; 49(9):1422-8. PubMed ID: 18703597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph node metastasis of squamous cell carcinoma from an unknown primary in the upper and middle neck: Impact of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography.
    Deron PB; Bonte KM; Vermeersch HF; Van de Wiele C
    Cancer Biother Radiopharm; 2011 Jun; 26(3):331-4. PubMed ID: 21711095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-fluoride PET/CT for bone scanning. Role of attenuation correction.
    Nagarajah J; Dannat T; Hartung V; Bockisch A; Rosenbaum-Krumme S
    Nuklearmedizin; 2012; 51(3):84-7. PubMed ID: 22366817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.